Breast Cancer Prognosis Assessment CapitalBio

Features of Breast Cancer Prognosis Assessment

Genes covered by this test

• Newly diagnosed breast cancer patients with stage I or II, estrogen receptor positive, lymph node metastasis negative, and to be treated with tamoxifen.

• Menopausal patients with lymph node-positive, estrogen receptor-positive invasive breast cancer.

The Importance of Regular Follow-ups in Breast Cancer Prognosis

CapitalBio Technology, a leading company in the field of medical technology, emphasizes the importance of regular follow-ups in breast cancer prognosis. Here are some key points to consider:

1. Early Detection of Recurrence: Regular follow-ups allow for the early detection of any recurrence or metastasis of breast cancer. This early detection can significantly improve the prognosis and provide more treatment options.

2. Monitoring Treatment Response: Follow-ups are crucial in monitoring the patient’s response to treatment. Through prognosis assessment, doctors can determine if the treatment is working or if adjustments need to be made.

3. Patient Support and Guidance: Regular follow-ups provide an opportunity for patients to discuss any concerns or side effects they may be experiencing. This ongoing communication can help patients feel more supported and informed about their prognosis.

4. Updating Prognosis: Breast cancer prognosis can change over time. Regular follow-ups allow for the prognosis to be updated based on the latest test results and the patient’s overall health status.

5. Promoting Healthy Lifestyle: Follow-ups also provide an opportunity to reinforce the importance of a healthy lifestyle in improving breast cancer prognosis. This includes regular exercise, a balanced diet, and avoiding risk factors like smoking.

6. Psychological Well-being: Regular follow-ups can also help monitor and address the psychological impact of a breast cancer diagnosis and treatment, which can significantly affect a patient’s prognosis.